These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6750192)
1. The effect of high-sodium intake and furosemide on blood pressure and other related variables in salt-sensitive hypertension. Fujita T Jpn J Med; 1982 Apr; 21(2):157-8. PubMed ID: 6750192 [No Abstract] [Full Text] [Related]
2. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension. Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004 [No Abstract] [Full Text] [Related]
3. Factors influencing blood pressure in salt-sensitive patients with hypertension. Fujita T; Henry WL; Bartter FC; Lake CR; Delea CS Am J Med; 1980 Sep; 69(3):334-44. PubMed ID: 6998291 [No Abstract] [Full Text] [Related]
4. Plasma and urinary norepinephrine values at extremes of sodium intake in normal man. Luft FC; Rankin LI; Henry DP; Bloch R; Grim CE; Weyman AE; Murray RH; Weinberger MH Hypertension; 1979; 1(3):261-6. PubMed ID: 399238 [No Abstract] [Full Text] [Related]
5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system. Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244 [TBL] [Abstract][Full Text] [Related]
7. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension. Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385 [No Abstract] [Full Text] [Related]
8. Enhanced vascular reactivity to norepinephrine in salt-sensitive patients with hypertension. Shikuma R; Yoshimura M; Ashizawa H; Kajita Y; Takahashi H; Takeda K; Ijichi H Jpn Heart J; 1982 Nov; 23(6):861-9. PubMed ID: 6761453 [TBL] [Abstract][Full Text] [Related]
9. [Effects of excessive salt-loading on blood pressure, plasma norepinephrine concentration, plasma renin activity, plasma aldosterone concentration and urinary aldosterone excretion in patients with essential hypertension and normotensive subjects]. Atarashi K Nihon Naika Gakkai Zasshi; 1983 Jan; 72(1):38-46. PubMed ID: 6343533 [No Abstract] [Full Text] [Related]
10. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension. Scherer B; Witzgall H; Weber PC Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651 [TBL] [Abstract][Full Text] [Related]
11. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects]. Beyer J; Liebau G; Steiner B; Schick K; Hayduk K Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577 [No Abstract] [Full Text] [Related]
12. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients. Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018 [TBL] [Abstract][Full Text] [Related]
13. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man. Abe K; Sato M; Imai Y; Haruyama T; Sato K; Hiwatari M; Kasai Y; Yoshinaga K Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957 [No Abstract] [Full Text] [Related]
14. Norepinephrine and calcium responses to altered sodium intake in modulating and non-modulating high-renin hypertension. Burgess ED; Keane PM; Watanabe M J Hypertens Suppl; 1988 Dec; 6(4):S85-7. PubMed ID: 3071599 [TBL] [Abstract][Full Text] [Related]
15. 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension. Laffer CL; Laniado-Schwartzman M; Wang MH; Nasjletti A; Elijovich F Hypertension; 2003 Mar; 41(3 Pt 2):703-8. PubMed ID: 12623983 [TBL] [Abstract][Full Text] [Related]
16. Effect of sodium intake on prostaglandin A, renin and aldosterone in normotensive humans. Payakkapan W; Attallah AA; Lee JB; Carr AA Kidney Int Suppl; 1975 Sep; ():S283-90. PubMed ID: 1059808 [No Abstract] [Full Text] [Related]
17. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension. Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; MancheƱo E; Millet VG; Sancho J; Rodicio JL Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008 [TBL] [Abstract][Full Text] [Related]
18. Sodium sensitivity in normotensive human subjects. Luft FC; Weinberger MH; Grim CE; Fineberg NS; Miller JZ Ann Intern Med; 1983 May; 98(5 Pt 2):758-62. PubMed ID: 6342495 [TBL] [Abstract][Full Text] [Related]
19. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension. Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087 [No Abstract] [Full Text] [Related]
20. Salt-sensitivity in borderline hypertension. Fujita T; Noda H; Ando K; Sato Y; Ito Y Jpn Circ J; 1984 Nov; 48(11):1285-7. PubMed ID: 6389924 [No Abstract] [Full Text] [Related] [Next] [New Search]